Is homocysteine a risk factor for the incidence of coronary artery disease in patients with end-stage renal disease?;Ist homocystein ein risikofaktor fur das vorliegen einer koronaren herzkrankheit bei patienten mit terminaler niereninsuffizienz?

Medizinische Klinik

Volumn 95, Issue 4, 2000, Pages 189-194

  Klusmann, Anne ^b   Ivens, Katrin ^a   Schadewaldt, Peter ^b   Grabensee, Bernd ^b   Heering, Peter ^b  

^a Klin Nephrologie Rheumatol H   (Germany)

^b NONE

Author keywords

Coronary artery disease; End stage renal disease; Hyperhomocysteinemia

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CORRELATION FUNCTION; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; AGED; CHRONIC KIDNEY FAILURE; KIDNEY FUNCTION TEST; MIDDLE AGED;

ADULT; AGED; CORONARY DISEASE; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0034654657     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/pl00002105     Document Type: Article

References (21)

1. Arnadottir M, Hulteberg B, Wahlberg J, et al. Serum total homocysteine concentration before and after renal tranplantation. Kidney Int 1998;54:1380-4.
2. Bachmann J, Tepel M, Raidt H, et al. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 1995;6:121-5.
3. Bostom A, Brosman JT, Hall B, et al. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1996;116:59-62.
4. Bostom A, Shemian D, Lapane KL, et al. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis 1995; 114:93-103.
5. Brattström L. Vitamins as homocysteine-lowering agents. J Nutr 1996;126:1276-80.
6. Chauveau P, Chadefaux B, Coude M, et al. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;43:72-7.
7. Clarke R., Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-54.
8. Den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-62.
9. Dudman NPD, Guo XW, Gordon RB, et al. Human homocysteine catabolism: Three major pathways and their relevance to development of arterial occlusive disease. J Nutr 1996;126:1295-300.
10. Harpel PC, Zhang X, Borth W. Homocysteine and hemostasis: pathogenetic mechanisms predisposing to thrombosis. J Nutr 1996;126:1285-9.
11. Heinecke JW, Rosen H, Suzuki LA, et al. The role of sulphur-containing amino acids in superoxide production and modification of low-density-lipoproteine by arterial smooth muscle cells. J Biol Chem 1989; 262:10098-103.
12. Malinow M, Duell P, Hess D, et al. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998;338:1009-15.
13. Moustapha A, Naso A, Nahlawi M, et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 1998;97:138-41.
14. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;336:230-6.
15. Parfrey PS, Foley RN, Harnett JD, et al. Outcome and risk factors of ischemic heart disease in chronic uremia. Kidney Int 1996;45:1428-34.
16. Raine T, Margreiter AE, Brunner FP, et al. Report on management of renal failure in Europe, XXII. Nephrol Dial Transplant 1992;7:Suppl 2:7-35.
17. Robinson K, Gupta A, Dennis V, et al. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 1996;94:2743-8.
18. Selhub J, Jaques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
19. Smolin LA, Laidlav SA, Kopple JD. Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis. Am J Clin Nutr 1987;45:737.
20. Stampfer M, Malinow R, Willett W, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US-physicians. JAMA 1992;268:877-81.
21. Wall RT, Harlan JM, Harker LA, et al. Homocysteine-induced endothelial cell injury in vitro, a model for the study of vascular injury. Thromb Res 1980;18:113-121.